# All-Case Surveillance of Ofev in Patients With IPF in Japan

> **NCT02607722** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 10117 (actual)

## Conditions studied

- Idiopathic Pulmonary Fibrosis

## Interventions

- **DRUG:** Nintedanib

## Key facts

- **NCT ID:** NCT02607722
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08-31
- **Primary completion:** 2023-05-02
- **Final completion:** 2023-05-02
- **Target enrollment:** 10117 (ACTUAL)
- **Last updated:** 2024-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02607722

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02607722, "All-Case Surveillance of Ofev in Patients With IPF in Japan". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02607722. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*